News

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and ...
Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...
Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.
A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...
Weight loss medications containing liraglutide could provide significant relief for millions of migraine sufferers, according ...
Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda (R)) Lexaria has now demonstrated, in distinct human clinical ...
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines ...